RAPHAELE ALAURA: Open Payments
NPI 1821693037 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 10 payments from 2 companies in 2025. Trend: 2023 $1,397 · 2024 $2,326 · 2025 $610
Long term medical supply or device loan: $482Food & beverage: $128
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $572 |
| Celgene Corporation | 2 | $39 |
Products named: KISQALI, SCEMBLIX, REBLOZYL.
Industry payments across NV — which companies pay providers there.
